Quick Takeaways
- INTRACOASTAL CAPITAL, LLC filed SCHEDULE 13G for Silexion Therapeutics Corp Ordinary shares, par value $0.0009 per share (SLXN).
- Disclosed ownership: 5%.
- Date of event: 15 Jan 2025.
INTRACOASTAL CAPITAL, LLC - 15 Jan 2025 SCHEDULE 13G Report for Silexion Therapeutics Corp Ordinary shares, par value $0.0009 per share (SLXN)
- Filing Manager
- INTRACOASTAL CAPITAL, LLC
- Reporting Manager
- Mitchell P. Kopin
- Symbol
- SLXN
- Shares outstanding
- 4,204,950 shares
- Disclosed Ownership
- 209,827 shares
- Ownership
- 5%
- Form type
- SCHEDULE 13G
- Filing time
- 21 Jan 2025, 17:49:11 UTC
- Date of event
- 15 Jan 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"INTRACOASTAL CAPITAL, LLC disclosed 5% ownership in Silexion Therapeutics Corp Ordinary shares, par value $0.0009 per share (SLXN) on 15 Jan 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 21 Jan 2025, 17:49.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Mitchell P. Kopin | 5% | 209,827 | 0 | 209,827 | /s/ Mitchell P. Kopin | Mitchell P. Kopin | |
| Daniel B. Asher | 5% | 209,827 | 0 | 209,827 | /s/ Daniel B. Asher | Daniel B. Asher | |
| Intracoastal Capital LLC | 5% | 209,827 | 0 | 209,827 | /s/ Mitchell P. Kopin | Mitchell P. Kopin/Manager |